1-2 of 2
Elisabeth A Lasater, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Resistance of Natural Killer and T Cells to Venetoclax Allows for Combination Treatment with Cancer Immunotherapy Agents

Elisabeth A Lasater, PhD, An D Do, Luciana Burton, Yijin Li, Erin Williams, Jason Oeh, Luciana Molinero, Elicia Penuel, Deepak Sampath, Monique Dail, Marcia Belvin, Teiko Sumiyoshi, Elizabeth A Punnoose, Jeffrey Venstrom, Aparna Raval
Journal: Blood
Blood (2018) 132 (Supplement 1): 1118.
https://doi.org/10.1182/blood-2018-99-116405
Published: 2018
Journal Articles

FLT3-ITD Activation Mediates Resistance to the BCL-2 Selective Antagonist, Venetoclax, in FLT3-ITD Mutant AML Models

Raghuveer Singh Mali, PhD, Elisabeth A. Lasater, PhD, Kelly Doyle, Ritu Malla, Erwin Boghaert, Andrew Souers, Joel D. Leverson, PhD, Deepak Sampath, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1348.
https://doi.org/10.1182/blood.V130.Suppl_1.1348.1348
Published: 2017